Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kaatz

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
The American Journal of Medicine|February 7, 2018
Risk of Venous Thromboembolism Following Peripherally Inserted Central Catheter Exchange: An Analysis of 23,000 Hospitalized PatientsVineet Chopra, Scott Kaatz, Paul Grant, et al.
Journal of Hospital Medicine|January 30, 2018
Patterns and Predictors of Short-Term Peripherally Inserted Central Catheter Use: A Multicenter Prospective Cohort StudyDavid Paje, Anna Conlon, Scott Kaatz, et al.
American Journal of Hematology|March 28, 2019
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation ForumAdam Cuker, Allison Burnett, Darren Triller, et al.
The American Journal of Cardiology|September 23, 2008
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)Alex C Spyropoulos, Alexander G G Turpie, Andrew S Dunn, et al.
Joint Commission Journal on Quality and Patient Safety|February 2, 2020
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of PerformanceWilliam E Dager, Jack Ansell, Geoffrey D Barnes, et al.
Current Medical Research and Opinion|May 12, 2018
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty dischargeFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
The American Journal of Medicine|April 25, 2016
Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical PatientsM Todd Greene, Alex C Spyropoulos, Vineet Chopra, et al.
Current Medical Research and Opinion|April 18, 2014
Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulantsFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolismJeffrey S Berger, Roger Seheult, François Laliberté, et al.
Current Medical Research and Opinion|November 23, 2017
Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillationScott Kaatz, Craig I Coleman, Brahim Bookhart, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
The American Journal of Medicine|February 7, 2018
Risk of Venous Thromboembolism Following Peripherally Inserted Central Catheter Exchange: An Analysis of 23,000 Hospitalized PatientsVineet Chopra, Scott Kaatz, Paul Grant, et al.
Journal of Hospital Medicine|January 30, 2018
Patterns and Predictors of Short-Term Peripherally Inserted Central Catheter Use: A Multicenter Prospective Cohort StudyDavid Paje, Anna Conlon, Scott Kaatz, et al.
American Journal of Hematology|March 28, 2019
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation ForumAdam Cuker, Allison Burnett, Darren Triller, et al.
The American Journal of Cardiology|September 23, 2008
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)Alex C Spyropoulos, Alexander G G Turpie, Andrew S Dunn, et al.
Joint Commission Journal on Quality and Patient Safety|February 2, 2020
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of PerformanceWilliam E Dager, Jack Ansell, Geoffrey D Barnes, et al.
Current Medical Research and Opinion|May 12, 2018
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty dischargeFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
The American Journal of Medicine|April 25, 2016
Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical PatientsM Todd Greene, Alex C Spyropoulos, Vineet Chopra, et al.
Current Medical Research and Opinion|April 18, 2014
Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulantsFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolismJeffrey S Berger, Roger Seheult, François Laliberté, et al.
Current Medical Research and Opinion|November 23, 2017
Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillationScott Kaatz, Craig I Coleman, Brahim Bookhart, et al.
Pageof 17